| Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study M Slifstein, E Van De Giessen, J Van Snellenberg, JL Thompson, ... JAMA psychiatry 72 (4), 316-324, 2015 | 425 | 2015 |
| The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis CM Corcoran, D Kimhy, MA Parrilla-Escobar, VL Cressman, AD Stanford, ... Psychological medicine 41 (2), 251-261, 2011 | 192 | 2011 |
| Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms JL Thompson, MF Pogue-Geile, AA Grace Schizophrenia bulletin 30 (4), 875-900, 2004 | 180 | 2004 |
| Increased prefrontal cortical D1 receptors in drug naïve patients with schizophrenia: a PET study with [11C]NNC112 A Abi-Dargham, X Xu, JL Thompson, R Gil, LS Kegeles, N Urban, ... Journal of psychopharmacology 26 (6), 794-805, 2012 | 159 | 2012 |
| Childhood trauma and prodromal symptoms among individuals at clinical high risk for psychosis JL Thompson, M Kelly, D Kimhy, JM Harkavy-Friedman, S Khan, ... Schizophrenia research 108 (1-3), 176-181, 2009 | 157 | 2009 |
| Dopamine release in chronic cannabis users: a [11c] raclopride positron emission tomography study NBL Urban, M Slifstein, JL Thompson, X Xu, RR Girgis, S Raheja, ... Biological psychiatry 71 (8), 677-683, 2012 | 147 | 2012 |
| Striatal and extrastriatal dopamine release measured with PET and [18F] fallypride M Slifstein, LS Kegeles, X Xu, JL Thompson, N Urban, J Castrillon, ... Synapse 64 (5), 350-362, 2010 | 141 | 2010 |
| Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients DR Rosell, JL Thompson, M Slifstein, X Xu, WG Frankle, AS New, ... Biological psychiatry 67 (12), 1154-1162, 2010 | 119 | 2010 |
| Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis CM Corcoran, D Kimhy, A Stanford, S Khan, J Walsh, J Thompson, ... Schizophrenia research 106 (2-3), 286-293, 2008 | 112 | 2008 |
| Striatal dopamine release in schizophrenia comorbid with substance dependence JL Thompson, N Urban, M Slifstein, X Xu, LS Kegeles, RR Girgis, ... Molecular psychiatry 18 (8), 909-915, 2013 | 109 | 2013 |
| Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F] fallypride positron emission tomography LS Kegeles, M Slifstein, X Xu, N Urban, JL Thompson, T Moadel, ... Biological psychiatry 68 (7), 634-641, 2010 | 88 | 2010 |
| Presynaptic dopamine in schizophrenia N Miyake, J Thompson, M Skinbjerg, A Abi‐Dargham CNS neuroscience & therapeutics 17 (2), 104-109, 2011 | 73 | 2011 |
| Indicators of genetic liability to schizophrenia: a sibling study of neuropsychological performance JL Thompson, JR Watson, SR Steinhauer, G Goldstein, MF Pogue-Geile Schizophrenia Bulletin 31 (1), 85-96, 2005 | 66 | 2005 |
| A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia RR Girgis, JX Van Snellenberg, A Glass, LS Kegeles, JL Thompson, ... Journal of Psychopharmacology 30 (5), 428-435, 2016 | 56 | 2016 |
| Dynamic shifts in brain network activation during supracapacity working memory task performance JX Van Snellenberg, M Slifstein, C Read, J Weber, JL Thompson, ... Human brain mapping 36 (4), 1245-1264, 2015 | 55 | 2015 |
| HPA-axis function, symptoms, and medication exposure in youths at clinical high risk for psychosis G Sugranyes, JL Thompson, CM Corcoran Journal of psychiatric research 46 (11), 1389-1393, 2012 | 52 | 2012 |
| Anhedonia in the psychosis risk syndrome: associations with social impairment and basal orbitofrontal cortical activity VL Cressman, SA Schobel, S Steinfeld, S Ben-David, JL Thompson, ... npj Schizophrenia 1 (1), 1-7, 2015 | 36 | 2015 |
| Serotonin transporter availability in impulsive aggressive personality disordered patients: A PET study with [11C] DASB E van de Giessen, DR Rosell, JL Thompson, X Xu, RR Girgis, Y Ehrlich, ... Journal of psychiatric research 58, 147-154, 2014 | 36 | 2014 |
| Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: a PET study with [11 C] NNC112 JL Thompson, DR Rosell, M Slifstein, RR Girgis, X Xu, Y Ehrlich, ... Psychopharmacology 231 (21), 4231-4240, 2014 | 34 | 2014 |
| In vivo binding of the dopamine-1 receptor PET tracers [11 C] NNC112 and [11 C] SCH23390: a comparison study in individuals with schizophrenia EMP Poels, RR Girgis, JL Thompson, M Slifstein, A Abi-Dargham Psychopharmacology 228 (1), 167-174, 2013 | 26 | 2013 |
